KIT and ovarian carcinoma: Expression of miR-193a resulted in a significant down-regulation of c-KIT mRNA and E2F6 mRNA, thus suggesting that c-KIT mRNA and E2F6 mRNA are targets of miR-193a in ovarian cancer cells (Fig. 1B).